ID   ABCAC_HUMAN             Reviewed;        2595 AA.
AC   Q86UK0; Q53QE2; Q53S55; Q8IZW6; Q96JT3; Q9Y4M5;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   24-NOV-2009, sequence version 3.
DT   28-JUN-2023, entry version 174.
DE   RecName: Full=Glucosylceramide transporter ABCA12 {ECO:0000305};
DE            EC=7.6.2.1 {ECO:0000269|PubMed:16007253, ECO:0000269|PubMed:20869849};
DE   AltName: Full=ATP-binding cassette sub-family A member 12;
DE   AltName: Full=ATP-binding cassette transporter 12;
DE            Short=ATP-binding cassette 12;
GN   Name=ABCA12 {ECO:0000312|HGNC:HGNC:14637}; Synonyms=ABC12;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND VARIANT
RP   THR-777.
RC   TISSUE=Placenta;
RX   PubMed=12697999; DOI=10.1159/000069811;
RA   Annilo T., Shulemin S., Chen Z.Q., Arnould I., Prades C., Lemoine C.,
RA   Maintoux-Larois C., Devaud C., Dean M., Denefle P., Rosier M.;
RT   "Identification and characterization of a novel ABCA subfamily member,
RT   ABCA12, located in the lamellar ichthyosis region on 2q34.";
RL   Cytogenet. Genome Res. 98:169-176(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANT THR-777.
RC   TISSUE=Retina;
RA   Bonner T.I., Moses T., Detera-Wadleigh S.;
RT   "A retinal cDNA for the ATP-binding cassette transporter ABCA12.";
RL   Submitted (APR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 221-2595, AND VARIANT THR-777.
RA   Schaap F.G., van Wijland M., Groen A.K.;
RT   "Cloning of a novel ABC transporter (ABCA12) tentatively involved in lipid
RT   homeostatis.";
RL   Submitted (SEP-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2400-2595.
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   TISSUE SPECIFICITY, INDUCTION, SUBCELLULAR LOCATION, FUNCTION, VARIANTS
RP   ARCI4B 434-ARG--SER-2595 DEL; THR-1385 DEL AND 1950-ARG--SER-2595 DEL, AND
RP   CATALYTIC ACTIVITY.
RX   PubMed=16007253; DOI=10.1172/jci24834;
RA   Akiyama M., Sugiyama-Nakagiri Y., Sakai K., McMillan J.R., Goto M.,
RA   Arita K., Tsuji-Abe Y., Tabata N., Matsuoka K., Sasaki R., Sawamura D.,
RA   Shimizu H.;
RT   "Mutations in lipid transporter ABCA12 in harlequin ichthyosis and
RT   functional recovery by corrective gene transfer.";
RL   J. Clin. Invest. 115:1777-1784(2005).
RN   [7]
RP   DEVELOPMENTAL STAGE, TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=17591952; DOI=10.2353/ajpath.2007.061207;
RA   Yamanaka Y., Akiyama M., Sugiyama-Nakagiri Y., Sakai K., Goto M.,
RA   McMillan J.R., Ota M., Sawamura D., Shimizu H.;
RT   "Expression of the keratinocyte lipid transporter ABCA12 in developing and
RT   reconstituted human epidermis.";
RL   Am. J. Pathol. 171:43-52(2007).
RN   [8]
RP   TISSUE SPECIFICITY, SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=17927575; DOI=10.1111/j.1600-0625.2007.00614.x;
RA   Sakai K., Akiyama M., Sugiyama-Nakagiri Y., McMillan J.R., Sawamura D.,
RA   Shimizu H.;
RT   "Localization of ABCA12 from Golgi apparatus to lamellar granules in human
RT   upper epidermal keratinocytes.";
RL   Exp. Dermatol. 16:920-926(2007).
RN   [9]
RP   INDUCTION.
RX   PubMed=17611579; DOI=10.1038/sj.jid.5700944;
RA   Jiang Y.J., Lu B., Kim P., Paragh G., Schmitz G., Elias P.M.,
RA   Feingold K.R.;
RT   "PPAR and LXR activators regulate ABCA12 expression in human
RT   keratinocytes.";
RL   J. Invest. Dermatol. 128:104-109(2008).
RN   [10]
RP   TISSUE SPECIFICITY, AND FUNCTION.
RX   PubMed=19179616; DOI=10.2353/ajpath.2009.080860;
RA   Thomas A.C., Tattersall D., Norgett E.E., O'Toole E.A., Kelsell D.P.;
RT   "Premature terminal differentiation and a reduction in specific proteases
RT   associated with loss of ABCA12 in Harlequin ichthyosis.";
RL   Am. J. Pathol. 174:970-978(2009).
RN   [11]
RP   INDUCTION.
RX   PubMed=19429679; DOI=10.1074/jbc.m109.006973;
RA   Jiang Y.J., Uchida Y., Lu B., Kim P., Mao C., Akiyama M., Elias P.M.,
RA   Holleran W.M., Grunfeld C., Feingold K.R.;
RT   "Ceramide stimulates ABCA12 expression via peroxisome proliferator-
RT   activated receptor {delta} in human keratinocytes.";
RL   J. Biol. Chem. 284:18942-18952(2009).
RN   [12]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=20869849; DOI=10.1016/j.jdermsci.2010.08.012;
RA   Mitsutake S., Suzuki C., Akiyama M., Tsuji K., Yanagi T., Shimizu H.,
RA   Igarashi Y.;
RT   "ABCA12 dysfunction causes a disorder in glucosylceramide accumulation
RT   during keratinocyte differentiation.";
RL   J. Dermatol. Sci. 60:128-129(2010).
RN   [13]
RP   TISSUE SPECIFICITY.
RX   PubMed=32072744; DOI=10.15252/embr.201948692;
RA   Ursino G.M., Fu Y., Cottle D.L., Mukhamedova N., Jones L.K., Low H.,
RA   Tham M.S., Gan W.J., Mellett N.A., Das P.P., Weir J.M., Ditiatkovski M.,
RA   Fynch S., Thorn P., Thomas H.E., Meikle P.J., Parkington H.C., Smyth I.M.,
RA   Sviridov D.;
RT   "ABCA12 regulates insulin secretion from beta-cells.";
RL   EMBO Rep. 21:e48692-e48692(2020).
RN   [14]
RP   REVIEW ON VARIANTS, AND INVOLVEMENT IN ARCI.
RX   PubMed=20672373; DOI=10.1002/humu.21326;
RA   Akiyama M.;
RT   "ABCA12 mutations and autosomal recessive congenital ichthyosis: a review
RT   of genotype/phenotype correlations and of pathogenetic concepts.";
RL   Hum. Mutat. 31:1090-1096(2010).
RN   [15]
RP   VARIANTS ARCI4A SER-1380; GLU-1381; HIS-1514; LYS-1539 AND SER-1651.
RX   PubMed=12915478; DOI=10.1093/hmg/ddg235;
RA   Lefevre C., Audebert S., Jobard F., Bouadjar B., Lakhdar H.,
RA   Boughdene-Stambouli O., Blanchet-Bardon C., Heilig R., Foglio M.,
RA   Weissenbach J., Lathrop M., Prud'homme J.F., Fischer J.;
RT   "Mutations in the transporter ABCA12 are associated with lamellar
RT   ichthyosis type 2.";
RL   Hum. Mol. Genet. 12:2369-2378(2003).
RN   [16]
RP   VARIANT ASN-2365.
RX   PubMed=15756637; DOI=10.1086/429844;
RA   Kelsell D.P., Norgett E.E., Unsworth H., Teh M.-T., Cullup T., Mein C.A.,
RA   Dopping-Hepenstal P.J., Dale B.A., Tadini G., Fleckman P., Stephens K.G.,
RA   Sybert V.P., Mallory S.B., North B.V., Witt D.R., Sprecher E.,
RA   Taylor A.E.M., Ilchyshyn A., Kennedy C.T., Goodyear H., Moss C., Paige D.,
RA   Harper J.I., Young B.D., Leigh I.M., Eady R.A.J., O'Toole E.A.;
RT   "Mutations in ABCA12 underlie the severe congenital skin disease harlequin
RT   ichthyosis.";
RL   Am. J. Hum. Genet. 76:794-803(2005).
RN   [17]
RP   VARIANT ARCI4B ASN-387.
RX   PubMed=16675967; DOI=10.1038/sj.jid.5700295;
RA   Akiyama M., Sakai K., Sugiyama-Nakagiri Y., Yamanaka Y., McMillan J.R.,
RA   Sawamura D., Niizeki H., Miyagawa S., Shimizu H.;
RT   "Compound heterozygous mutations including a de novo missense mutation in
RT   ABCA12 led to a case of harlequin ichthyosis with moderate clinical
RT   severity.";
RL   J. Invest. Dermatol. 126:1518-1523(2006).
RN   [18]
RP   VARIANT ARCI4B ARG-1179.
RX   PubMed=16902423; DOI=10.1038/sj.jid.5700455;
RA   Thomas A.C., Cullup T., Norgett E.E., Hill T., Barton S., Dale B.A.,
RA   Sprecher E., Sheridan E., Taylor A.E., Wilroy R.S., DeLozier C.,
RA   Burrows N., Goodyear H., Fleckman P., Stephens K.G., Mehta L., Watson R.M.,
RA   Graham R., Wolf R., Slavotinek A., Martin M., Bourn D., Mein C.A.,
RA   O'Toole E.A., Kelsell D.P.;
RT   "ABCA12 is the major harlequin ichthyosis gene.";
RL   J. Invest. Dermatol. 126:2408-2413(2006).
RN   [19]
RP   VARIANTS ARCI4A PRO-345 AND THR-1494.
RX   PubMed=17508018; DOI=10.1038/sj.jid.5700885;
RA   Natsuga K., Akiyama M., Kato N., Sakai K., Sugiyama-Nakagiri Y.,
RA   Nishimura M., Hata H., Abe M., Arita K., Tsuji-Abe Y., Onozuka T.,
RA   Aoyagi S., Kodama K., Ujiie H., Tomita Y., Shimizu H.;
RT   "Novel ABCA12 mutations identified in two cases of non-bullous congenital
RT   ichthyosiform erythroderma associated with multiple skin malignant
RT   neoplasia.";
RL   J. Invest. Dermatol. 127:2669-2673(2007).
RN   [20]
RP   VARIANT ARCI4A ASP-1136.
RX   PubMed=18284401; DOI=10.1111/j.1365-2133.2008.08439.x;
RA   Akiyama M., Sakai K., Hatamochi A., Yamazaki S., McMillan J.R., Shimizu H.;
RT   "Novel compound heterozygous nonsense and missense ABCA12 mutations lead to
RT   nonbullous congenital ichthyosiform erythroderma.";
RL   Br. J. Dermatol. 158:864-867(2008).
RN   [21]
RP   VARIANT [LARGE SCALE ANALYSIS] VAL-476.
RX   PubMed=18772397; DOI=10.1126/science.1164368;
RA   Jones S., Zhang X., Parsons D.W., Lin J.C., Leary R.J., Angenendt P.,
RA   Mankoo P., Carter H., Kamiyama H., Jimeno A., Hong S.M., Fu B., Lin M.T.,
RA   Calhoun E.S., Kamiyama M., Walter K., Nikolskaya T., Nikolsky Y.,
RA   Hartigan J., Smith D.R., Hidalgo M., Leach S.D., Klein A.P., Jaffee E.M.,
RA   Goggins M., Maitra A., Iacobuzio-Donahue C., Eshleman J.R., Kern S.E.,
RA   Hruban R.H., Karchin R., Papadopoulos N., Parmigiani G., Vogelstein B.,
RA   Velculescu V.E., Kinzler K.W.;
RT   "Core signaling pathways in human pancreatic cancers revealed by global
RT   genomic analyses.";
RL   Science 321:1801-1806(2008).
RN   [22]
RP   VARIANTS ARCI4A SER-1235; HIS-1514; LEU-1798 AND LYS-1980.
RX   PubMed=19262603; DOI=10.1038/jid.2009.23;
RA   Sakai K., Akiyama M., Yanagi T., McMillan J.R., Suzuki T., Tsukamoto K.,
RA   Sugiyama H., Hatano Y., Hayashitani M., Takamori K., Nakashima K.,
RA   Shimizu H.;
RT   "ABCA12 is a major causative gene for non-bullous congenital ichthyosiform
RT   erythroderma.";
RL   J. Invest. Dermatol. 129:2306-2309(2009).
RN   [23]
RP   VARIANT ARCI4A VAL-1559.
RX   PubMed=22257947; DOI=10.1684/ejd.2011.1638;
RA   Nawaz S., Tariq M., Ahmad I., Malik N.A., Baig S.M., Dahl N., Klar J.;
RT   "Non-bullous congenital ichthyosiform erythroderma associated with
RT   homozygosity for a novel missense mutation in an ATP binding domain of
RT   ABCA12.";
RL   Eur. J. Dermatol. 22:178-181(2012).
CC   -!- FUNCTION: Transports lipids such as glucosylceramides from the outer to
CC       the inner leaflet of lamellar granules (LGs) membrane, whereby the
CC       lipids are finally transported to the keratinocyte periphery via the
CC       trans-Golgi network and LGs and released to the apical surface of the
CC       granular keratinocytes to form lipid lamellae in the stratum corneum of
CC       the epidermis, which is essential for skin barrier function
CC       (PubMed:16007253, PubMed:20869849). In the meantime, participates in
CC       the transport of the lamellar granules-associated proteolytic enzymes,
CC       in turn regulates desquamation and keratinocyte differentiation
CC       (PubMed:19179616). Furthermore, is essential for the regulation of
CC       cellular cholesterol homeostasis by regulating ABCA1-dependent
CC       cholesterol efflux from macrophages through interaction with NR1H2 and
CC       ABCA1 (By similarity). Plays pleiotropic roles in regulating glucose
CC       stimulated insulin secretion from beta cells, regulating the morphology
CC       and fusion of insulin granules, lipid raft abundance and the actin
CC       cytoskeleton (By similarity). Also involved in lung surfactant
CC       biogenesis (By similarity). {ECO:0000250|UniProtKB:E9Q876,
CC       ECO:0000269|PubMed:16007253, ECO:0000269|PubMed:19179616,
CC       ECO:0000269|PubMed:20869849}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + phospholipidSide 1 = ADP + phosphate +
CC         phospholipidSide 2.; EC=7.6.2.1;
CC         Evidence={ECO:0000269|PubMed:16007253, ECO:0000269|PubMed:20869849};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + beta-D-glucosylceramide(in) + H2O = ADP + beta-D-
CC         glucosylceramide(out) + H(+) + phosphate; Xref=Rhea:RHEA:66660,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:83264, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000269|PubMed:16007253, ECO:0000269|PubMed:20869849};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66661;
CC         Evidence={ECO:0000305|PubMed:16007253, ECO:0000305|PubMed:20869849};
CC   -!- SUBUNIT: Interacts with NR1H2 and ABCA1; this interaction is required
CC       for ABCA1 localization to the cell surface and is necessary for its
CC       normal activity and stability. {ECO:0000250|UniProtKB:E9Q876}.
CC   -!- INTERACTION:
CC       Q86UK0; O95477: ABCA1; NbExp=4; IntAct=EBI-9541582, EBI-784112;
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle membrane
CC       {ECO:0000269|PubMed:16007253, ECO:0000269|PubMed:17927575}; Multi-pass
CC       membrane protein {ECO:0000305}. Golgi apparatus membrane
CC       {ECO:0000269|PubMed:17927575}. Note=Localizes in the limiting membrane
CC       of the lamellar granules (LGs) (PubMed:17927575). Trafficks from the
CC       Golgi apparatus to the lamellar granules (LGs) at the cell periphery in
CC       the uppermost granular layer keratinocytes where ABCA12-positive LGs
CC       fuse with the keratinocyte-cell membrane to secrete their lipid content
CC       to the extracellular space of the stratum corneum (PubMed:16007253,
CC       PubMed:17927575). Co-localizes through the Golgi apparatus to the cell
CC       periphery with glucosylceramide (PubMed:17927575).
CC       {ECO:0000269|PubMed:16007253, ECO:0000269|PubMed:17927575}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q86UK0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q86UK0-2; Sequence=VSP_011283, VSP_011284;
CC   -!- TISSUE SPECIFICITY: Mainly expressed in the stomach, placenta, testis
CC       and fetal brain (PubMed:12697999). Expressed in the upper epidermal
CC       layers, mainly the granular layers, of skin (PubMed:16007253,
CC       PubMed:17591952, PubMed:17927575). Expressed throughout the normal
CC       interfollicular epidermis with prominent expression in the stratum
CC       granulosum (PubMed:19179616). Expressed in alpha and beta cells of
CC       pancreatic islets (PubMed:32072744). {ECO:0000269|PubMed:12697999,
CC       ECO:0000269|PubMed:16007253, ECO:0000269|PubMed:17591952,
CC       ECO:0000269|PubMed:17927575, ECO:0000269|PubMed:19179616,
CC       ECO:0000269|PubMed:32072744}.
CC   -!- DEVELOPMENTAL STAGE: At about 6 to 9 weeks estimated gestational age
CC       (EGA), expressed in the periderm during the early period when the two-
CC       layered epidermis form. At 10 to 13 weeks EGA, expressed in the entire
CC       epidermis with high expression in periderm until to 14 to 22 weeks EGA.
CC       {ECO:0000269|PubMed:17591952}.
CC   -!- INDUCTION: Up-regulated during keratinization (PubMed:16007253). Up-
CC       regulated after 15 weeks estimated gestational age (EGA)
CC       (PubMed:17591952). Highly up-regulated by PPARG activators such as
CC       ciglitazone, troglitazone, and the PPARD activator GW 0742 in time- and
CC       dose-dependent manner but independently of keratinocyte
CC       differentiation. In addition, modestly up-regulated by the NR1H3 and
CC       NR1H2 activator TO901317 in an keratinocyte differentiation-independent
CC       manner (PubMed:17611579). Up-regulated by N-(hexanoyl)sphing-4-enine in
CC       a time- and dose-dependent manner or by glucosyltransferase inhibitors,
CC       ceramidase inhibitors and sphingomyelin synthase inhibitors that
CC       increase endogenous ceramide levels and induce ABCA12 expression via
CC       the PPARD signaling pathway (PubMed:19429679). Up-regulated by N-
CC       acetylsphingosine in a time- and dose-dependent manner via the PPARD
CC       signaling pathway (Probable). {ECO:0000269|PubMed:16007253,
CC       ECO:0000269|PubMed:17591952, ECO:0000269|PubMed:17611579,
CC       ECO:0000269|PubMed:19429679, ECO:0000305|PubMed:19429679}.
CC   -!- DOMAIN: Multifunctional polypeptide with two homologous halves, each
CC       containing a hydrophobic membrane-anchoring domain and an ATP binding
CC       cassette (ABC) domain. {ECO:0000250}.
CC   -!- DISEASE: Ichthyosis, congenital, autosomal recessive 4A (ARCI4A)
CC       [MIM:601277]: A form of autosomal recessive congenital ichthyosis, a
CC       disorder of keratinization with abnormal differentiation and
CC       desquamation of the epidermis, resulting in abnormal skin scaling over
CC       the whole body. The main skin phenotypes are lamellar ichthyosis (LI)
CC       and non-bullous congenital ichthyosiform erythroderma (NCIE), although
CC       phenotypic overlap within the same patient or among patients from the
CC       same family can occur. Lamellar ichthyosis is a condition often
CC       associated with an embedment in a collodion-like membrane at birth;
CC       skin scales later develop, covering the entire body surface. Non-
CC       bullous congenital ichthyosiform erythroderma characterized by fine
CC       whitish scaling on an erythrodermal background; larger brownish scales
CC       are present on the buttocks, neck and legs.
CC       {ECO:0000269|PubMed:12915478, ECO:0000269|PubMed:17508018,
CC       ECO:0000269|PubMed:18284401, ECO:0000269|PubMed:19262603,
CC       ECO:0000269|PubMed:22257947}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Ichthyosis, congenital, autosomal recessive 4B (ARCI4B)
CC       [MIM:242500]: A rare, very severe form of congenital ichthyosis, in
CC       which the neonate is born with a thick covering of armor-like scales.
CC       The skin dries out to form hard diamond-shaped plaques separated by
CC       fissures, resembling 'armor plating'. The normal facial features are
CC       severely affected, with distortion of the lips (eclabion), eyelids
CC       (ectropion), ears, and nostrils. Affected babies are often born
CC       prematurely and rarely survive the perinatal period. Babies who survive
CC       into infancy and beyond develop skin changes resembling severe non-
CC       bullous congenital ichthyosiform erythroderma.
CC       {ECO:0000269|PubMed:16007253, ECO:0000269|PubMed:16675967,
CC       ECO:0000269|PubMed:16902423}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ABC transporter superfamily. ABCA family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAN40735.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=ABCMdb; Note=Database for mutations in ABC proteins;
CC       URL="http://abcm2.hegelab.org/search";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY219711; AAP21093.1; -; mRNA.
DR   EMBL; AY033486; AAK54355.1; -; mRNA.
DR   EMBL; AC072062; AAY24276.1; -; Genomic_DNA.
DR   EMBL; AC114780; AAY24230.1; -; Genomic_DNA.
DR   EMBL; AF418105; AAN40735.1; ALT_INIT; mRNA.
DR   EMBL; AL080207; CAB45776.1; -; mRNA.
DR   CCDS; CCDS33372.1; -. [Q86UK0-1]
DR   CCDS; CCDS33373.1; -. [Q86UK0-2]
DR   PIR; T12512; T12512.
DR   RefSeq; NP_056472.2; NM_015657.3. [Q86UK0-2]
DR   RefSeq; NP_775099.2; NM_173076.2. [Q86UK0-1]
DR   AlphaFoldDB; Q86UK0; -.
DR   SMR; Q86UK0; -.
DR   BioGRID; 117585; 8.
DR   IntAct; Q86UK0; 5.
DR   MINT; Q86UK0; -.
DR   STRING; 9606.ENSP00000272895; -.
DR   TCDB; 3.A.1.211.13; the atp-binding cassette (abc) superfamily.
DR   GlyCosmos; Q86UK0; 35 sites, No reported glycans.
DR   GlyGen; Q86UK0; 36 sites, 1 O-linked glycan (1 site).
DR   iPTMnet; Q86UK0; -.
DR   PhosphoSitePlus; Q86UK0; -.
DR   SwissPalm; Q86UK0; -.
DR   BioMuta; ABCA12; -.
DR   DMDM; 269849713; -.
DR   EPD; Q86UK0; -.
DR   jPOST; Q86UK0; -.
DR   MassIVE; Q86UK0; -.
DR   MaxQB; Q86UK0; -.
DR   PaxDb; Q86UK0; -.
DR   PeptideAtlas; Q86UK0; -.
DR   ProteomicsDB; 69821; -. [Q86UK0-1]
DR   ProteomicsDB; 69822; -. [Q86UK0-2]
DR   Antibodypedia; 34220; 147 antibodies from 26 providers.
DR   DNASU; 26154; -.
DR   Ensembl; ENST00000272895.12; ENSP00000272895.7; ENSG00000144452.15. [Q86UK0-1]
DR   Ensembl; ENST00000389661.4; ENSP00000374312.4; ENSG00000144452.15. [Q86UK0-2]
DR   GeneID; 26154; -.
DR   KEGG; hsa:26154; -.
DR   MANE-Select; ENST00000272895.12; ENSP00000272895.7; NM_173076.3; NP_775099.2.
DR   UCSC; uc002vev.4; human. [Q86UK0-1]
DR   AGR; HGNC:14637; -.
DR   CTD; 26154; -.
DR   DisGeNET; 26154; -.
DR   GeneCards; ABCA12; -.
DR   GeneReviews; ABCA12; -.
DR   HGNC; HGNC:14637; ABCA12.
DR   HPA; ENSG00000144452; Tissue enhanced (breast, skin).
DR   MalaCards; ABCA12; -.
DR   MIM; 242500; phenotype.
DR   MIM; 601277; phenotype.
DR   MIM; 607800; gene.
DR   neXtProt; NX_Q86UK0; -.
DR   OpenTargets; ENSG00000144452; -.
DR   Orphanet; 79394; Congenital ichthyosiform erythroderma.
DR   Orphanet; 457; Harlequin ichthyosis.
DR   Orphanet; 313; Lamellar ichthyosis.
DR   PharmGKB; PA29604; -.
DR   VEuPathDB; HostDB:ENSG00000144452; -.
DR   eggNOG; KOG0059; Eukaryota.
DR   GeneTree; ENSGT00940000157295; -.
DR   HOGENOM; CLU_000604_19_7_1; -.
DR   InParanoid; Q86UK0; -.
DR   OMA; VPIPDNR; -.
DR   OrthoDB; 6951at2759; -.
DR   PhylomeDB; Q86UK0; -.
DR   TreeFam; TF105191; -.
DR   PathwayCommons; Q86UK0; -.
DR   Reactome; R-HSA-1369062; ABC transporters in lipid homeostasis.
DR   Reactome; R-HSA-5682294; Defective ABCA12 causes ARCI4B.
DR   SignaLink; Q86UK0; -.
DR   BioGRID-ORCS; 26154; 6 hits in 1147 CRISPR screens.
DR   ChiTaRS; ABCA12; human.
DR   GeneWiki; ABCA12; -.
DR   GenomeRNAi; 26154; -.
DR   Pharos; Q86UK0; Tbio.
DR   PRO; PR:Q86UK0; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q86UK0; protein.
DR   Bgee; ENSG00000144452; Expressed in penis and 75 other tissues.
DR   ExpressionAtlas; Q86UK0; baseline and differential.
DR   Genevisible; Q86UK0; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0097209; C:epidermal lamellar body; IDA:BHF-UCL.
DR   GO; GO:0097234; C:epidermal lamellar body membrane; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; NAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0030658; C:transport vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0140359; F:ABC-type transporter activity; IEA:InterPro.
DR   GO; GO:0034191; F:apolipoprotein A-I receptor binding; IPI:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; NAS:UniProtKB.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   GO; GO:0140326; F:ATPase-coupled intramembrane lipid transporter activity; IEA:UniProtKB-EC.
DR   GO; GO:0034040; F:ATPase-coupled lipid transmembrane transporter activity; IC:BHF-UCL.
DR   GO; GO:0042626; F:ATPase-coupled transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0005319; F:lipid transporter activity; IDA:BHF-UCL.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:BHF-UCL.
DR   GO; GO:0019725; P:cellular homeostasis; NAS:UniProtKB.
DR   GO; GO:0006672; P:ceramide metabolic process; IDA:UniProtKB.
DR   GO; GO:0035627; P:ceramide transport; IDA:UniProtKB.
DR   GO; GO:0033344; P:cholesterol efflux; IEA:Ensembl.
DR   GO; GO:0003336; P:corneocyte desquamation; IMP:UniProtKB.
DR   GO; GO:0061436; P:establishment of skin barrier; ISS:UniProtKB.
DR   GO; GO:0006886; P:intracellular protein transport; IMP:UniProtKB.
DR   GO; GO:0031424; P:keratinization; IEA:Ensembl.
DR   GO; GO:0055088; P:lipid homeostasis; IEA:Ensembl.
DR   GO; GO:0006869; P:lipid transport; IDA:BHF-UCL.
DR   GO; GO:0048286; P:lung alveolus development; IEA:Ensembl.
DR   GO; GO:0033700; P:phospholipid efflux; IMP:BHF-UCL.
DR   GO; GO:0010875; P:positive regulation of cholesterol efflux; IDA:BHF-UCL.
DR   GO; GO:0032379; P:positive regulation of intracellular lipid transport; ISS:UniProtKB.
DR   GO; GO:2000010; P:positive regulation of protein localization to cell surface; IEA:Ensembl.
DR   GO; GO:0072659; P:protein localization to plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0045055; P:regulated exocytosis; IMP:BHF-UCL.
DR   GO; GO:0061178; P:regulation of insulin secretion involved in cellular response to glucose stimulus; ISS:UniProtKB.
DR   GO; GO:0045616; P:regulation of keratinocyte differentiation; IMP:UniProtKB.
DR   GO; GO:0032940; P:secretion by cell; IMP:BHF-UCL.
DR   GO; GO:0043129; P:surfactant homeostasis; IEA:Ensembl.
DR   CDD; cd03263; ABC_subfamily_A; 2.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 2.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR003439; ABC_transporter-like_ATP-bd.
DR   InterPro; IPR017871; ABC_transporter-like_CS.
DR   InterPro; IPR026082; ABCA.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR19229:SF36; ABC TRANSPORTER A FAMILY MEMBER 7-RELATED; 1.
DR   PANTHER; PTHR19229; ATP-BINDING CASSETTE TRANSPORTER SUBFAMILY A ABCA; 1.
DR   Pfam; PF12698; ABC2_membrane_3; 2.
DR   Pfam; PF00005; ABC_tran; 2.
DR   SMART; SM00382; AAA; 2.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 2.
DR   PROSITE; PS00211; ABC_TRANSPORTER_1; 1.
DR   PROSITE; PS50893; ABC_TRANSPORTER_2; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cytoplasmic vesicle; Disease variant;
KW   Glycoprotein; Golgi apparatus; Ichthyosis; Lipid transport; Membrane;
KW   Nucleotide-binding; Reference proteome; Repeat; Translocase; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..2595
FT                   /note="Glucosylceramide transporter ABCA12"
FT                   /id="PRO_0000093300"
FT   TRANSMEM        23..43
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1065..1085
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1112..1132
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1145..1165
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1174..1194
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1200..1220
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1250..1270
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1747..1767
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1979..1999
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        2035..2055
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        2072..2092
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        2103..2123
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        2187..2207
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        2270..2290
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          1346..1577
FT                   /note="ABC transporter 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   DOMAIN          2254..2489
FT                   /note="ABC transporter 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   REGION          2571..2595
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         1378..1385
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   BINDING         2290..2297
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   CARBOHYD        156
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        174
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        214
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        275
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        333
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        367
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        383
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        412
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        435
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        528
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        543
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        577
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        608
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        623
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        648
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        752
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        826
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        920
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        963
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1170
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1524
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1663
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1704
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1769
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1819
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1835
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1876
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1921
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1952
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2178
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2208
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2223
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2318
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2542
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2547
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..318
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_011283"
FT   VAR_SEQ         319..328
FT                   /note="LLYTLDSPAQ -> MFTYIKIITS (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_011284"
FT   VARIANT         199
FT                   /note="W -> C (in dbSNP:rs16853238)"
FT                   /id="VAR_055473"
FT   VARIANT         237
FT                   /note="N -> H (in dbSNP:rs11890512)"
FT                   /id="VAR_055474"
FT   VARIANT         274
FT                   /note="Q -> R (in dbSNP:rs11890468)"
FT                   /id="VAR_055475"
FT   VARIANT         287
FT                   /note="R -> G (in dbSNP:rs11891778)"
FT                   /id="VAR_055476"
FT   VARIANT         345
FT                   /note="T -> P (in ARCI4A; skin phenotype consistent with
FT                   non-bullous congenital ichthyosiform erythroderma;
FT                   dbSNP:rs1295935868)"
FT                   /evidence="ECO:0000269|PubMed:17508018"
FT                   /id="VAR_067075"
FT   VARIANT         387
FT                   /note="S -> N (in ARCI4B; dbSNP:rs746315995)"
FT                   /evidence="ECO:0000269|PubMed:16675967"
FT                   /id="VAR_067076"
FT   VARIANT         434..2595
FT                   /note="Missing (in ARCI4B)"
FT                   /evidence="ECO:0000269|PubMed:16007253"
FT                   /id="VAR_084428"
FT   VARIANT         459
FT                   /note="S -> T (in dbSNP:rs113112835)"
FT                   /id="VAR_019597"
FT   VARIANT         476
FT                   /note="A -> V (in a pancreatic ductal adenocarcinoma
FT                   sample; somatic mutation; dbSNP:rs370640837)"
FT                   /evidence="ECO:0000269|PubMed:18772397"
FT                   /id="VAR_062663"
FT   VARIANT         550
FT                   /note="E -> G (in dbSNP:rs16853149)"
FT                   /id="VAR_027444"
FT   VARIANT         777
FT                   /note="S -> T (in dbSNP:rs7560008)"
FT                   /evidence="ECO:0000269|PubMed:12697999, ECO:0000269|Ref.2,
FT                   ECO:0000269|Ref.4"
FT                   /id="VAR_027445"
FT   VARIANT         1136
FT                   /note="G -> D (in ARCI4A; skin phenotype consistent with
FT                   non-bullous congenital ichthyosiform erythroderma)"
FT                   /evidence="ECO:0000269|PubMed:18284401"
FT                   /id="VAR_067077"
FT   VARIANT         1179
FT                   /note="G -> R (in ARCI4B; dbSNP:rs267606622)"
FT                   /evidence="ECO:0000269|PubMed:16902423"
FT                   /id="VAR_067078"
FT   VARIANT         1235
FT                   /note="W -> S (in ARCI4A; skin phenotype consistent with
FT                   non-bullous congenital ichthyosiform erythroderma)"
FT                   /evidence="ECO:0000269|PubMed:19262603"
FT                   /id="VAR_067079"
FT   VARIANT         1251
FT                   /note="G -> D (in dbSNP:rs13414448)"
FT                   /id="VAR_027446"
FT   VARIANT         1380
FT                   /note="N -> S (in ARCI4A; dbSNP:rs28940269)"
FT                   /evidence="ECO:0000269|PubMed:12915478"
FT                   /id="VAR_019598"
FT   VARIANT         1381
FT                   /note="G -> E (in ARCI4A; dbSNP:rs28940268)"
FT                   /evidence="ECO:0000269|PubMed:12915478"
FT                   /id="VAR_019599"
FT   VARIANT         1385
FT                   /note="Missing (in ARCI4B; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:16007253"
FT                   /id="VAR_084429"
FT   VARIANT         1494
FT                   /note="I -> T (in ARCI4A; skin phenotype consistent with
FT                   non-bullous congenital ichthyosiform erythroderma;
FT                   dbSNP:rs1263698595)"
FT                   /evidence="ECO:0000269|PubMed:17508018"
FT                   /id="VAR_067080"
FT   VARIANT         1514
FT                   /note="R -> H (in ARCI4A; dbSNP:rs28940270)"
FT                   /evidence="ECO:0000269|PubMed:12915478,
FT                   ECO:0000269|PubMed:19262603"
FT                   /id="VAR_019600"
FT   VARIANT         1539
FT                   /note="E -> K (in ARCI4A; dbSNP:rs28940271)"
FT                   /evidence="ECO:0000269|PubMed:12915478"
FT                   /id="VAR_019601"
FT   VARIANT         1546
FT                   /note="R -> C (in dbSNP:rs13401480)"
FT                   /id="VAR_027447"
FT   VARIANT         1559
FT                   /note="G -> V (in ARCI4A; skin phenotype consistent with
FT                   non-bullous congenital ichthyosiform erythroderma;
FT                   dbSNP:rs1457513156)"
FT                   /evidence="ECO:0000269|PubMed:22257947"
FT                   /id="VAR_067081"
FT   VARIANT         1651
FT                   /note="G -> S (in ARCI4A; dbSNP:rs28940568)"
FT                   /evidence="ECO:0000269|PubMed:12915478"
FT                   /id="VAR_019602"
FT   VARIANT         1798
FT                   /note="P -> L (in ARCI4A; skin phenotype consistent with
FT                   non-bullous congenital ichthyosiform erythroderma;
FT                   dbSNP:rs181314573)"
FT                   /evidence="ECO:0000269|PubMed:19262603"
FT                   /id="VAR_067082"
FT   VARIANT         1950..2595
FT                   /note="Missing (in ARCI4B; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:16007253"
FT                   /id="VAR_084430"
FT   VARIANT         1980
FT                   /note="T -> K (in ARCI4A; skin phenotype consistent with
FT                   non-bullous congenital ichthyosiform erythroderma;
FT                   dbSNP:rs763858530)"
FT                   /evidence="ECO:0000269|PubMed:19262603"
FT                   /id="VAR_067083"
FT   VARIANT         2064
FT                   /note="E -> K (in dbSNP:rs1213011)"
FT                   /id="VAR_027448"
FT   VARIANT         2365
FT                   /note="D -> N (in dbSNP:rs726070)"
FT                   /evidence="ECO:0000269|PubMed:15756637"
FT                   /id="VAR_027449"
FT   CONFLICT        651
FT                   /note="Y -> D (in Ref. 1; AAP21093)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        811
FT                   /note="Y -> H (in Ref. 1; AAP21093)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        826
FT                   /note="N -> D (in Ref. 2; AAK54355)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2079
FT                   /note="Y -> H (in Ref. 1; AAP21093)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   2595 AA;  293237 MW;  5B71359B642BBAE6 CRC64;
     MASLFHQLQI LVWKNWLGVK RQPLWTLVLI LWPVIIFIIL AITRTKFPPT AKPTCYLAPR
     NLPSTGFFPF LQTLLCDTDS KCKDTPYGPQ DLLRRKGIDD ALFKDSEILR KSSNLDKDSS
     LSFQSTQVPE RRHASLATVF PSPSSDLEIP GTYTFNGSQV LARILGLEKL LKQNSTSEDI
     RRELCDSYSG YIVDDAFSWT FLGRNVFNKF CLSNMTLLES SLQELNKQFS QLSSDPNNQK
     IVFQEIVRML SFFSQVQEQK AVWQLLSSFP NVFQNDTSLS NLFDVLRKAN SVLLVVQKVY
     PRFATNEGFR TLQKSVKHLL YTLDSPAQGD SDNITHVWNE DDGQTLSPSS LAAQLLILEN
     FEDALLNISA NSPYIPYLAC VRNVTDSLAR GSPENLRLLQ STIRFKKSFL RNGSYEDYFP
     PVPEVLKSKL SQLRNLTELL CESETFSLIE KSCQLSDMSF GSLCEESEFD LQLLEAAELG
     TEIAASLLYH DNVISKKVRD LLTGDPSKIN LNMDQFLEQA LQMNYLENIT QLIPIIEAML
     HVNNSADASE KPGQLLEMFK NVEELKEDLR RTTGMSNRTI DKLLAIPIPD NRAEIISQVF
     WLHSCDTNIT TPKLEDAMKE FCNLSLSERS RQSYLIGLTL LHYLNIYNFT YKVFFPRKDQ
     KPVEKMMELF IRLKEILNQM ASGTHPLLDK MRSLKQMHLP RSVPLTQAMY RSNRMNTPQG
     SFSTISQALC SQGITTEYLT AMLPSSQRPK GNHTKDFLTY KLTKEQIASK YGIPINSTPF
     CFSLYKDIIN MPAGPVIWAF LKPMLLGRIL YAPYNPVTKA IMEKSNVTLR QLAELREKSQ
     EWMDKSPLFM NSFHLLNQAI PMLQNTLRNP FVQVFVKFSV GLDAVELLKQ IDELDILRLK
     LENNIDIIDQ LNTLSSLTVN ISSCVLYDRI QAAKTIDEME REAKRLYKSN ELFGSVIFKL
     PSNRSWHRGY DSGNVFLPPV IKYTIRMSLK TAQTTRSLRT KIWAPGPHNS PSHNQIYGRA
     FIYLQDSIER AIIELQTGRN SQEIAVQVQA IPYPCFMKDN FLTSVSYSLP IVLMVAWVVF
     IAAFVKKLVY EKDLRLHEYM KMMGVNSCSH FFAWLIESVG FLLVTIVILI IILKFGNILP
     KTNGFILFLY FSDYSFSVIA MSYLISVFFN NTNIAALIGS LIYIIAFFPF IVLVTVENEL
     SYVLKVFMSL LSPTAFSYAS QYIARYEEQG IGLQWENMYT SPVQDDTTSF GWLCCLILAD
     SFIYFLIAWY VRNVFPGTYG MAAPWYFPIL PSYWKERFGC AEVKPEKSNG LMFTNIMMQN
     TNPSASPEYM FSSNIEPEPK DLTVGVALHG VTKIYGSKVA VDNLNLNFYE GHITSLLGPN
     GAGKTTTISM LTGLFGASAG TIFVYGKDIK TDLHTVRKNM GVCMQHDVLF SYLTTKEHLL
     LYGSIKVPHW TKKQLHEEVK RTLKDTGLYS HRHKRVGTLS GGMKRKLSIS IALIGGSRVV
     ILDEPSTGVD PCSRRSIWDV ISKNKTARTI ILSTHHLDEA EVLSDRIAFL EQGGLRCCGS
     PFYLKEAFGD GYHLTLTKKK SPNLNANAVC DTMAVTAMIQ SHLPEAYLKE DIGGELVYVL
     PPFSTKVSGA YLSLLRALDN GMGDLNIGCY GISDTTVEEV FLNLTKESQK NSAMSLEHLT
     QKKIGNSNAN GISTPDDLSV SSSNFTDRDD KILTRGERLD GFGLLLKKIM AILIKRFHHT
     RRNWKGLIAQ VILPIVFVTT AMGLGTLRNS SNSYPEIQIS PSLYGTSEQT AFYANYHPST
     EALVSAMWDF PGIDNMCLNT SDLQCLNKDS LEKWNTSGEP ITNFGVCSCS ENVQECPKFN
     YSPPHRRTYS SQVIYNLTGQ RVENYLISTA NEFVQKRYGG WSFGLPLTKD LRFDITGVPA
     NRTLAKVWYD PEGYHSLPAY LNSLNNFLLR VNMSKYDAAR HGIIMYSHPY PGVQDQEQAT
     ISSLIDILVA LSILMGYSVT TASFVTYVVR EHQTKAKQLQ HISGIGVTCY WVTNFIYDMV
     FYLVPVAFSI GIIAIFKLPA FYSENNLGAV SLLLLLFGYA TFSWMYLLAG LFHETGMAFI
     TYVCVNLFFG INSIVSLSVV YFLSKEKPND PTLELISETL KRIFLIFPQF CFGYGLIELS
     QQQSVLDFLK AYGVEYPNET FEMNKLGAMF VALVSQGTMF FSLRLLINES LIKKLRLFFR
     KFNSSHVRET IDEDEDVRAE RLRVESGAAE FDLVQLYCLT KTYQLIHKKI IAVNNISIGI
     PAGECFGLLG VNGAGKTTIF KMLTGDIIPS SGNILIRNKT GSLGHVDSHS SLVGYCPQED
     ALDDLVTVEE HLYFYARVHG IPEKDIKETV HKLLRRLHLM PFKDRATSMC SYGTKRKLST
     ALALIGKPSI LLLDEPSSGM DPKSKRHLWK IISEEVQNKC SVILTSHSME ECEALCTRLA
     IMVNGKFQCI GSLQHIKSRF GRGFTVKVHL KNNKVTMETL TKFMQLHFPK TYLKDQHLSM
     LEYHVPVTAG GVANIFDLLE TNKTALNITN FLVSQTTLEE VFINFAKDQK SYETADTSSQ
     GSTISVDSQD DQMES
//
